Nihon Kohden Of Japan To Distribute Cyberonics Device If Approved
This article was originally published in PharmAsia News
Executive Summary
Japan's Nihon Kohden has agreed with U.S.-based Cyberonics to distribute the Houston company's VNS Therapy Systems in Japan. The deal is subject to approval of the implanted device for vagus nerve stimulation by Japanese authorities. The U.S. FDA already has approved VNS for treating refractory epilepsy and depression resistant to other treatments. Cyberonics began distributing VNS in China last year. (Click here for more